Published on in Vol 8 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49515, first published .
Persuasive Systems Design Trends in Coronary Heart Disease Management: Scoping Review of Randomized Controlled Trials

Persuasive Systems Design Trends in Coronary Heart Disease Management: Scoping Review of Randomized Controlled Trials

Persuasive Systems Design Trends in Coronary Heart Disease Management: Scoping Review of Randomized Controlled Trials

Review

Oulu Advanced Research on Service and Information Systems, Faculty of Information Technology and Electrical Engineering, University of Oulu, Oulu, Finland

Corresponding Author:

Eunice Eno Yaa Frimponmaa Agyei, PhD

Oulu Advanced Research on Service and Information Systems

Faculty of Information Technology and Electrical Engineering

University of Oulu

Pentti Kaiteran katu 1

Oulu, 90570

Finland

Phone: 358 0449511559

Email: eunice.agyei@oulu.fi


Background: Behavior change support systems (BCSSs) have the potential to help people maintain healthy lifestyles and aid in the self-management of coronary heart disease (CHD). The Persuasive Systems Design (PSD) model is a framework for designing and evaluating systems designed to support lifestyle modifications and health behavior change using information and communication technology. However, evidence for the underlying design principles behind BCSSs for CHD has not been extensively reported in the literature.

Objective: This scoping review aims to identify existing health BCSSs for CHD, report the characteristics of these systems, and describe the persuasion context and persuasive design principles of these systems based on the PSD framework.

Methods: Using the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines, 3 digital databases (Scopus, Web of Science, and MEDLINE) were searched between 2010 to 2022. The major inclusion criteria for studies were in accordance with the PICO (Population, Intervention, Comparison, and Outcome) approach.

Results: Searches conducted in the databases identified 1195 papers, among which 30 were identified as eligible for the review. The most interesting characteristics of the BCSSs were the predominant use of primary task support principles, followed by dialogue support and credibility support and the sparing use of social support principles. Theories of behavior change such as the Social Cognitive Theory and Self-Efficacy Theory were used often to underpin these systems. However, significant trends in the use of persuasive system features on par with behavior change theories could not be established from the reviewed studies. This points to the fact that there is still no theoretical consensus on how best to design interventions to promote behavior change in patients with CHD.

Conclusions: Our results highlight key software features for designing BCSSs for the prevention and management of CHD. We encourage designers of behavior change interventions to evaluate the techniques that contributed to the success of the intervention. Future research should focus on evaluating the effectiveness of the interventions, persuasive design principles, and behavior change theories using research methodologies such as meta-analysis.

JMIR Cardio 2024;8:e49515

doi:10.2196/49515

Keywords



Coronary heart disease (CHD), also referred to as coronary artery disease (CAD), is the third leading cause of death worldwide and is associated with 17.8 million deaths annually [1]. Despite its significant association with a high mortality rate, it is preventable. With risk factors such as a sedentary lifestyle, physical inactivity, smoking, poor diet, hypertension, and obesity, both pharmacological and nonpharmacological interventions have been proposed to mitigate this menace [2]. Existing evidence suggests that preventing CHD requires lifestyle and health behavior changes [3]. Digital interventions, particularly behavior change support systems (BCSSs), have the potential to reduce risky health behaviors, improve the well-being of the user, and promote healthy lifestyles in patients with CHD. These are information systems that are designed to form, alter, or reinforce the attitudes, behaviors, or compliance of their users voluntarily [4]. A key element in behavior and attitude change is persuasion; the intention to change the behavior of an individual via persuasion may lead to a positive behavioral outcome [5]. Over the past decade, BCSSs and persuasive design have received elaborate attention with strategies that stem from behavior change theories. Although the development of these systems has increased at a startling rate to promote behavior change, the persuasion context (ie, the interdependencies between the user, technology, and the problem domain) and persuasive systems design principles are often ignored [6].

The existing literature reviews have predominantly focused on determining the effectiveness of different kinds of health BCSSs in changing lifestyle behavior, controlling modifiable risk factors, and improving CHD patient outcomes using mobile technologies [7,8], web-based technologies [9], and telerehabilitation [10]. However, evidence on how these systems were developed (ie, the design principles) to achieve the reported behavior change outcomes is not clear [11,12]. Moreover, these studies have focused on specific technologies; hence, the evidence cannot be generalized for all CHD BCSSs. Designing for behavior change involves identifying behavioral goals [5] and gaining an understanding of the behavior change context including the behavior change strategies, system features, and theoretical foundations [13,14] that underpin it.

This scoping review seeks to address this gap by providing an overview of persuasive context and behavior change strategies that support the management of CHD. Identifying these features will provide designers and researchers with an understanding of the persuasion context and persuasive features in systems that seek to promote behavior change in patients with CHD. More specifically, this review seeks to answer the broad review question, What persuasive systems design trends are evident in the management of CHD? To answer this question, this review aims to identify existing health BCSSs, report the characteristics of these systems, and describe the persuasion context and persuasive system design principles of the identified BCSSs for CHD using the Persuasive Systems Design (PSD) model proposed by Oinas-Kukkonen and Harjumaa [13].

The PSD model is the most-used framework for designing and evaluating persuasive systems [15]. Built on theories from psychology, information systems, and other disciplines, the PSD model guides the analysis of the persuasion context, including recognizing the intent of the persuasion, understanding the persuasion event, and defining the strategies in use [13]. Recognizing the persuasion intent involves understanding the roles of the persuader, the persuadee, the change type (ie, compliance, behavior, and attitude change), and the outcome (ie, forming, altering, or reinforcing compliance, behavior, and attitude change). Understanding the persuasion event entails features and characteristics arising from the problem domain (ie, use context), the user (ie, user context), and technology (ie, technology context). Persuasive systems have information content (ie, message) and software features. Defining the strategy involves crafting the content of the message to be delivered, deciding how to present arguments, the route to deliver the message, and the persuasiveness of the message. The model also provides a structure for designing and evaluating persuasive systems based on 7 key postulates and 4 system design principles, including primary task support (supports the user to carry out the actions that will lead to the desired behavior), dialogue support (facilitates the interaction between the user and the technology), credibility support (enhances the perception of trust and reliability of the system), and social support (aids behavior change by leveraging social influence). Table 1 describes specific variables of the PSD model used in evaluating and analyzing the persuasion context and system design features of the reviewed studies.

Table 1. Description of Persuasive Systems Design (PSD) variables used in the analysis, based on Oinas-Kukkonen and Harjumaa [13].
FactorDescription
Analyzing the persuasion context

The intent


Intended outcome/changeThe intended outcomes of interest in this review will be classified as clinical outcomes, behavioral outcomes, psychological outcomes, and improved quality of life.


Designer/persuader biasThis refers to the unintentional influence that designers, developers, or creators have on the features, content, or functionalities of an intervention due to their viewpoints, experiences, or preferences.

Theevent


Use contextThe general application domain is health—specifically, CHDa as a preventable health condition.


User contextThe population of interest will be patients living with CHD.


Technology contextThis will include any technological platforms including wearable devices, mobile apps, and web apps.

The strategy


MessageThis will describe the content delivered to inform or educate the user to change their behavior.


RouteThis will describe how information and content are delivered to users via the direct route, which uses the user’s cognition, or the indirect route using societal cues.
Persuasive principles

Primary task supportSystem features that support CHD to perform their primary task by reducing the cognitive load associated with the activity

Dialogue supportSystem features that provide computer-human dialogue as a means of reinforcing and motivating patients with CHD to perform the primary task

Credibility supportSystem features that make the patients with CHD believe that the intervention is reliable and credible

Social supportSystem features that motivate patients with CHD using social influence

aCHD: coronary heart disease.

Drawing upon the PSD model, this research aims to provide an overview of BCSSs for managing CHD, report the characteristics of these systems, and describe the persuasion context and persuasive design principles. The rest of the paper is organized as follows: The Methods section describe how this research was conducted. The Results section reveals the findings of the research. This is followed by the Discussion section, which includes the implications of the findings and the conclusion.


Identification of Studies

This scoping review was conducted by following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) [16]. We conducted a scoping literature search in the Scopus, Web of Science, and MEDLINE electronic databases from 2010 to 2022 using the Population, Intervention, Comparison, and Outcome (PICO) approach. The search domains included patients with CHD aged 18 years and older (population), randomized controlled trial (RCT) and BCSSs for CHD (intervention), and behavior change (outcome). The following search string related to the PICO approach was used (“coronary artery disease” OR “coronary heart disease” OR “ischemic heart disease”) AND (“mobile” OR “smart phone” OR “smartphone” OR “web” OR “internet”) AND (“prevention” OR “intervention”). The literature search was limited to studies published from 2010 because the PSD framework was proposed in 2009. Thus, including studies from 2010 would reveal evidence-based research trends. The first and second authors (EEYFA and AE, respectively) carried out the literature search and study selection independently. Divergent opinions on study inclusion were resolved through consensus among the 3 authors.

Data Inclusion and Exclusion Criteria

The titles and abstracts were screened for keywords by the first and second authors. These authors downloaded the full text and examined if they were suitable using the following criteria. First, the study had to be an RCT on CHD, published in a peer-reviewed academic journal or conference, and written in the English language. Additionally, the study intervention had to be technology-mediated (ie, used mobile, web, or internet-based applications). Finally, the study intervention had to have the aim of promoting behavioral change, such as physical activity, diet, or smoking cessation to manage or prevent CHD.

Data Extraction

Using the inclusion and exclusion criteria previously outlined, 30 papers were selected and reviewed. These articles were reviewed using the PSD framework. Data extraction and coding were conducted by the first and second authors independently. The 2 authors read the articles, identified the textual descriptions applicable to the design features, and coded them in a Microsoft Excel (Microsoft Corp) spreadsheet. The third author (HO-K) verified and validated the extracted data. Disagreements were resolved by revisiting the specific papers and reviewing them together until a consensus was reached.

The characteristics of the persuasion context and persuasive design features were extracted. The data extracted from each article were as follows: (1) name of the intervention; (2) objective of the study, which reveals the intention of the intervention; (3) primary and secondary outcome(s) (ie, intended outcome); (4) features/characteristics of the problem domain (ie, use context); (5) description of the study participants (ie, user context); (6) description of the technology-dependent characteristics of the intervention (ie, technology context); (7) description of the target behavior, and (8) persuasive software features of the intervention.


Selection of Studies

The initial search produced 1195 articles that were distributed among the aforementioned databases. Duplicates were removed, leaving 181 papers. The articles were excluded by title if they did not contain the keywords “CHD” and “randomized controlled trial, ” while articles were excluded by abstract if the technological context was not mentioned and if the intervention was not targeted at either behavior change or clinical outcome. Consequently, 151 articles were excluded by title and abstract. Finally, 30 RCT studies were analyzed in this scoping review. Figure 1 highlights the selection process using the PRISMA-ScR flow diagram.

Figure 1. The PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) flow diagram of the study selection process.

Characteristics of the Included Studies

The 30 included RCTs were published in 16 different peer-reviewed journals, namely Journal of Medical Internet Research (n=5, 17%), JMIR MHealth and Uhealth (n=4, 13%), European Journal of Preventive Cardiology (n=3, 13%), Journal of Cardiopulmonary Rehabilitation and Prevention (n=3, 10%), Hearts (n=2, 7%), BMJ Open (n=2, 7%), Circulation (n=2, 7%), and the rest in JAMA, Lancet Digital Health, Plos ONE, Patient Education and Counseling, Journal of Cardiovascular Translational Research, Pharmacy Education, JAMA Cardiology, Coronary Artery Disease, and Health and Quality of Life Outcomes.

The study duration for all included RCTs ranged between 4 weeks to 52 weeks, and the sample size for study participants ranged between 84 and 879. Additionally, 70% (n=21) of the studies focused on patients with CHD, 10% (n=3) on patients with acute coronary syndrome, 7% (n=2) on patients with CAD, and the remaining 13% (n=4) on patients with CHD and diabetes, CHD and depression, ischemic heart disease, and clinical manifestation of atherosclerosis in the coronary, cerebral, or peripheral arteries.

Analyzing the Persuasion Context

Overview

As highlighted in Table 1, analyzing the persuasion context involves recognizing the intent of the persuasion, understanding the persuasion event, and defining the strategies in use.

The Intent

All studies stated the objective of their study, which reveals the intention of the persuader as well as the intention behind the intervention. The intention behind the interventions was to use information and communication technology to support patients with CHD to improve their health and lifestyle. The persuaders were researchers (ie, people who participated in the design), and in some cases, clinicians (when the study was intended to be used in a clinical setting). The persuadees were study participants who received the intervention in the RCT. In the design of the interventions, decisions regarding features and content were mostly influenced by the viewpoints, experiences, and assumptions of the design team. Only 17% (5/30) of studies involved users directly. These users were primarily involved in creating messages delivered through the intervention [17-21]. One (3%) study obtained feedback from users via a pilot test to improve the intervention [22]. Two (7%) studies disclosed the composition of their design team, yet users were not involved in the process [23,24]. Finally, 73% (n=22) of studies did not provide any information on the users/prospective users’ involvement in the design of the intervention. Given the potential effect of designer bias on the usability and effectiveness of an intervention, it is important to acknowledge this and put in measures to mitigate its effects.

We identified and classified the intended outcomes of the 30 included RCTs into 4 categories: clinical outcomes, behavioral outcomes, psychological outcomes, and improved quality of life. The distribution of identified intended outcomes in each publication year of the included studies is presented in Figure 2. Multimedia Appendix 1 contains more detailed information [17-46].

Figure 2. Distribution of intended outcomes. CHD: coronary heart disease.
The Event

Analyzing the event provided insights into the problem domain (use context), user characteristics (user context), and technology (technology context). Although the main user group was people who had been diagnosed with CHD, some of them had multiple health conditions, such as diabetes and depression, or needed to change at least one behavior (eg, smoking, physical inactivity, and medication adherence) to prevent further health complications. The varying characteristics of the use context presented unique scenarios and opportunities for health behavior change (Multimedia Appendix 2 [17-46]). Users were mainly older than 18 years. A total of 20 (67%) studies [17-22,24,25,28,30,31,33,35-37,39,40,43,46] required the users to be able to read and understand the text, while 2 studies (7%) [18,29] required users to be computer literate.

The RCTs were conducted on various continents, including Oceania, Asia, Europe, and North America. In Oceania, studies were conducted in Australia [17,20,30,43,45,46] and New Zealand [26,33-35,38]. In Asia, there were 6 (20%) studies conducted in China [19,21,27,28,32,36,42], 3% (n=1) from Singapore [23], 3% (n=1) from the Republic of Korea [25], 3% (n=1) from Indonesia [39], and 3% (n=1) from Pakistan [31]. In Europe, 7% (n=2) of studies were conducted in the United Kingdom [18,40], 3% (n=1) in Italy [44], 3% (n=1) in the Netherlands [22], 3% (n=1) in Belgium [29], and 3% (n=1) across multiple European countries [41]. Two (7%) studies were conducted in North America, namely, the United States [37] and Canada [24].

Furthermore, it was observed that the nationality and cultural factors of users influenced the design of the intervention. For example, in Dorje et al [27], the popular Chinese social media app WeChat, together with Chinese avatars, was used to educate patients. Moreover, different types of technologies were chosen for the design and development for various reasons. The selection of the type of technology was based on some characteristics of the problem and user domain. For example, an SMS or other type of text message was used for delivering the intervention in one study because of its ease of use and cost-effectiveness [20]. In China, WeChat, which has an instant messaging component, was used in 3 (10%) studies [27,36,42].

The Strategy

Exactly 25 (83%) studies stated that they used content in their intervention. The content presented to the users in the 25 studies was mainly to educate users and support the behavior change process. This implies that the user’s cognition was required to process the information presented to them. Additionally, the RCTs conducted in Oceania and North America presented content to their users via the interventions, while 2 (7%) RCTs in both Asia and Europe did not present any content. Multimedia Appendices 3 and 4 [17-46] contain additional details.

Within the included RCTs, half (n=15, 50%) incorporated behavior change theories in their intervention designs. The most used behavior change theory was Social Cognitive Theory (n=10, 33%) [17,19-21,24,28,31,35,38,45]. This was followed by Self-Efficacy Theory, which was used in 17% (n=5) of studies [26,33,34,37,38]. Two (7%) studies [17,20], used the Behavior Skill Model, Theory of Reasoned Action, Theory of Planned Behavior, and Control Theory. The Health Belief Model was used in 2 studies [23,31] and the Commonsense Model was used in 2 studies [26,35]. Meanwhile, the Health Action Process Approach theory [28] and Cognition and Behavior theory [42] were each used once. It was observed that the number of theories used across these studies varied from 1 to 5. Interestingly, none of the RCTs conducted in Europe used behavior change theories in their interventions (Multimedia Appendix 4).

Analyzing the Persuasive Features

Overview

System features that were used in the CHD interventions were identified and coded based on the PSD model software feature categories. As shown in Table 1, they comprised primary task support, dialogue support, credibility support, and social support. Multimedia Appendix 4 highlights the distribution of identified persuasive system features. Apart from Putra et al [39], all the analyzed interventions used a minimum of 1 persuasive feature and a maximum of 6 persuasive features. Features of the primary task support principle were the most used, while that of the social support principle was the least used in the interventions for patients with CHD (Multimedia Appendix 5 [17-46]).

Primary Task Support

Primary task support features assist the user in carrying out the primary tasks that lead to behavior change; they include personalization, self-monitoring, reduction, rehearsals, tunneling, tailoring, and simulation [13]. Personalization (n=23, 77%) and self-monitoring (n=18, 60%) were found to be the most widely represented primary task support features in the articles reviewed. Tailoring was identified in 6 (20%) studies. The reduction feature was identified in 1 (3%) study to grade tasks for users [18]. Features such as rehearsal, tunneling, and simulation were not identified. Personalization and semipersonalization were implemented in different forms, such as (1) selecting and providing educational content on CHD based on user characteristics, such as age and gender [40], and baseline characteristics [17,20,43], such as smoking status and diet; (2) using the preferred name of users [19,21,26,35,37] (semipersonalization); (3) using their smoking status and diet pattern [25] (semipersonalization); (4) sending messages at the preferred time of the user [26,35]; (5) individualized exercise programs [27,29,33,38,42]; (6) individualized feedback [28,45]; (7) customizable sounds for reminders [46]; (8) a personalized website based on risk factors [22]; and (9) personalized medication SMS text messages [31].

Self-monitoring was implemented by setting and tracking goals [18,24,40], monitoring physical activities [26,27,29,30,34,44], glucose monitoring [19], heart rate monitoring [27,42], monitoring of cardiovascular risk factors [45], blood pressure monitoring [21,32], step counting with a pedometer [26], and medication adherence using electronic pill bottles [37]. Different messages were tailored for different user groups. For example, different messages were delivered to smokers and nonsmokers [17,20,35,43], dietary messages for vegetarians and nonvegetarians [25] and tailored programs for the working population [23].

Dialogue Support

This support category comprises 7 system features, namely reminders, praise, rewards, liking, similarity, suggestions, and social role. Dialogue support incorporates forms of social or interpersonal interactions into feedback to encourage the user to respond to requests made by the intervention that may lead to behavior change [47]. Reminders, praise, rewards, suggestions, and social role were identified in the studies.

Reminders were the most used software feature in this category (n=13, 43%). Some examples of how reminders were implemented include reminders about behavior change to decrease CHD risk [17,20,43], exercise reminders [23,38], reminders to check blood pressure [27], push notifications [30], medication reminders [31,32,36,37,46], and checkup reminders [26]. This was followed by praise (n=12, 40%). The implementation of praise included individualized feedback to manage outcomes [27,28], motivational messages [29,33,41], personalized feedback on progress [33,40,42,45], and performance [18,26,34].

In addition to these, suggestions (n=3, 10%), rewards (n=10, 3%), and social roles (n=10, 3%) were used, albeit rarely. Suggestions were implemented by providing tips on overcoming hindrances [40], dietary recommendations [46], and information on various physical activities [33]. The social role feature was implemented via a virtual cardiologist coach who offered advice to users [27]. Reward in the form of social rewards was identified in the intervention by Devi et al [18]. Though the liking and similarity feature may have been present in the interventions, we could not evaluate it due to its subjective nature.

System Credibility Support

Design principles in this category support the credibility of the system as a function of persuasion. Its features include expertise, surface credibility, authority, third-party endorsement, real-world feel, trustworthiness, and verifiability. Here, the visual elements of the user interface, as well as the believability of the content of messages or information delivered via the intervention, are crucial. Expertise was evident in most of the interventions (n=10, 33%), as the content was created by experts. Multidisciplinary teams consisting of researchers, physicians, clinicians, therapists, and practitioners (ie, software developers) were involved in creating content for the interventions [17,19-21,23-25,31,36,43]. This was followed by authority (n=9, 30%) and verification (n=50, 17%). Authority was identified in several interventions [17,19-21,25,30,33,36,43]. This was in the form of citing health quotes from recognized authorities such as the National Heart Foundation of Australia and the American College for Sports Medicine. Verifiability was identified in 17% (n=5) of the interventions [22,23,25,27,33]. In these interventions, links were provided for fact-checking purposes. A total of 5 (17%) interventions were observed to implement the “real-world feel” feature such that participants could contact researchers or clinicians for various purposes [22-24,31,42].

Social Support

Social learning was the only social support feature identified in the analyzed interventions. The intervention enabled users to watch others go through a similar behavior change process [38]. Other features, such as social comparison, cooperation, social facilitation, normative influence, competition, and recognition, were not identified in the research articles. The minimal use of social support features may be associated with the tendency of these features to trigger high intensities of negative sentiment and emotional backfire [48,49].


Principal Findings and Implications

CHD is a severe health problem, with an increasing prevalence worldwide. Adopting a healthy lifestyle and being aware of CHD risk factors are essential for its prevention and management. This scoping review identified existing health BCSSs from RCTs, reported their characteristics, and analyzed the persuasion context and persuasive design principles of the systems identified for CHD self-management using the PSD model. We found that trends in the use of persuasive system features on par with behavior change theories were identified for only 50% (n=15) of the RCTs; this points to the fact that there is still no consensus on the need to use theories and the best approaches to design interventions to promote behavior change in patients with CHD.

The intention behind the BCSSs was to support patients with CHD to improve their health and lifestyle. The interventions analyzed sought to improve clinical outcomes, behavioral outcomes, psychological outcomes, and improved quality of life outcomes associated with CHD for their users. The analysis of the events provided insights into the problem domain, user characteristics, and technology-related factors. Although the main user group was people who had been diagnosed with CHD, some of them had multiple health conditions such as diabetes and depression or needed to change at least one behavior (eg, smoking, physical inactivity, and medication adherence) to prevent further health complications. Users of the interventions were aged at least 18 years, cognitively sound, and computer literate.

Different types of information technology platforms were chosen for BCSS design and development for various reasons. For example, SMS and other types of text messages were used for delivering the intervention in 3% (n=1) of the studies because of their ease of use and cost-effectiveness. Moreover, WeChat, an instant messaging app, was adopted because it is a widely used social networking site in China.

Furthermore, the analysis of the strategy showed that the content delivered via the BCSSs was for educational purposes and hence required users to engage their cognitive resources. Another interesting finding was the lack of educational content in 13% (n=4) of the interventions. One would expect BCSSs to have educational content because such content provides a means to educate patients and reinforce behavior change [50].

Additionally, although the RCTs conducted in Europe used at least one persuasive feature in their interventions, none of the studies mentioned the behavior change theory that underpinned the BCSS. Proponents of the use of behavior change theories argue that theories explain the mechanisms through which behavior change occurs [51]. Often, developers prioritize the use of behavior change techniques at the expense of gaining an in-depth understanding of the theories that underlie them [14]. A potential problem that may arise with the use of BCSSs without a solid theoretical foundation is the creation of conflicting mechanisms that can affect the system’s long-term effectiveness. This also points to the fact that there is still no consensus on the relevance of theories and best approaches to design interventions to promote behavior change in patients with CHD.

Another issue worth mentioning is designer or persuader bias and how it manifests itself in designing persuasive and behavior change interventions. This bias may have important ethical implications, as persuasive design decisions should be neither deceptive, manipulative, nor coercive [52]—nor cause harm to the users. Although a lot of emphasis has been placed on user-centered design in recent times, there may be a tendency for designers and developers to make design decisions affected by cognitive biases (such as the inability to evaluate all solutions to determine optimal solutions due to resource limitations) and illogical decisions (eg, intuitive reasoning, which uses low cognitive resources) [53]. In the design of BCSSs, persuader bias can manifest itself in, for example, the kind of content presented to users and the implementation of features. Designers are tasked to make design decisions based on insights generated from the context of use, user characteristics, and affordances of technology [13]. These decisions can influence the acceptability and, subsequently, the effectiveness of the system because users are sensitive to design features (eg, tailoring) [54]. From the results of the analysis, it appears that the involvement of users (eg, to create messages) may serve as a strategy to mitigate designer bias in the development of health interventions. Further research is needed to confirm this claim.

The findings from this review suggest that BCSSs have the potential to support the self-management of CHD and promote healthy lifestyles. Studies argue that the effectiveness of these systems depends on their design and implementation [55,56]. The major challenge that emerges is identifying the components of the BCSS and pertinent PSD features that are responsible for driving behavioral change [56]. This will require a deep understanding of the intricate interplay between various elements within the BCSS, such as behavior change theories, educational content, and persuasive features. Additionally, knowing the individual contribution of persuasive components and synergistic effects in this regard is desired [56]. Further research shows that the patterns of use of the intervention influence its effectiveness in achieving the desired outcome [57].

Apart from Putra et al [39], between 1 and 6 persuasive features were used in the analyzed BCSSs. In the primary task support category, personalization and self-monitoring were found to be the most widely represented features. Within the dialogue support category, reminders and praise were the most-used features. Expertise and authority were the most-used features regarding credibility, while social learning was the only feature identified in the social support category. The frequent use of these features may imply their importance for BCSSs developed for managing or preventing CHD.

Additionally, we found that feedback is closely related to praise in the PSD model, yet distinct based on the textual descriptions. Users can receive feedback that is not necessarily of a positive tone (like praise). Feedback can be given on the user’s performance, which may be motivational, constructive, or both. Another interesting finding was the use of the term “semipersonalization,” a form of personalization. Semipersonalization describes a weak level of personalization. This brings to light the commentary by Oinas-Kukkonen [58] on a concept called “personalization myopia,” which seeks to clarify the misunderstanding surrounding the level and type of personalization offered in mobile and web apps. The level and type of personalization identified in the studies varied. In the studies analyzed, personalization of content was widely used. For instance, mobile text message–based interventions simply used the names of users to indicate personalization. With that being said, some of the studies did clarify the use of the level of personalization by using semipersonalization. A critical look at some studies revealed the use of user data to generate personalized content other than just the name. This is a step in the right direction toward true personalization. True personalization requires detailed information, such as the user’s preferences, to create individualized experiences [59] in the different stages of the user’s journey through the app. Moreover, the use of personalization accounts for differences in preferences between and within groups of participants [60].

It was reassuring that design principles that make the system credible were identified in 60% (n=18) of the BCSSs studied. System credibility support principles tend to increase user satisfaction and influence their intention to use an intervention [61]. Incorporating this principle shows the intention and commitment of the designers to deliver credible content and a trustworthy system.

Limitations

We acknowledge some limitations in our work. First, we relied on textual descriptions provided in the original papers, which were subjectively interpreted by the reviewers, creating an avenue for subjective bias. Second, our study is based on English-language publications only, thus excluding publications in other languages that could provide rich content to this analysis. Third, this review did not analyze the effectiveness of the analyzed interventions as it fell beyond the scope of this research. Instead, the focus was on identifying trends in persuasive design characteristics used in BCSSs for CHD. This encompassed key persuasive elements like behavior change theories, techniques, educational content, and persuasive features in the analyzed studies. Also, recognizing prevailing trends can contribute to the refinement and development of theories and practices for BCSSs. This valuable information can also help developers, clinicians, and developers to make informed decisions. To deepen our understanding, future research should assess the relevance and impact of persuasive elements through meta-analysis. This approach may yield much-needed evidence and insights and contribute to developing effective interventions.

Conclusion

This study sought to identify persuasive design characteristics in mobile, web, and other information system interventions for CHD. We analyzed 30 peer-reviewed RCT papers that implemented BCSSs for patients with CHD. This study highlights the key issues that should be considered when designing and developing BCSSs for CHD. From the analysis of RCTs, we found that trends in the use of persuasive system features on par with behavior change theories were identified for only 50% (n=15) of RCTs. This points to the fact that there is still no consensus on the need to use theories and the best approaches to design interventions to promote behavior change in patients with CHD. Although we were able to highlight the trends in the persuasive features, we were unable to determine if these features influenced the effectiveness of the analyzed BCSSs. Moreover, there is a need to evaluate the actual effect of the intervention on users. Thus, future research should address this using data analysis methodologies such as meta-analysis.

Acknowledgments

We would like to thank Markku Savolainen, MD and Piiastiina Tikka, PhD, for their feedback and comments on an early draft of this paper. Additionally, we would like to express our gratitude to Sami Pohjolainen for his thorough review of the Persuasive Systems Design features. This study has received funding from the European Union’s Horizon 2020 research and innovation program (grant 848056) and from the Academy of Finland project, known as PerFeat (decision 351670). It reflects only the authors’ views and neither the Commission of Finland nor the Academy of Finland are responsible for any use that may be made of the information it contains.

Data Availability

The data used in this research is publicly available in the Multimedia Appendices.

Conflicts of Interest

None declared.

Multimedia Appendix 1

The analysis of intent describes the primary and secondary outcomes of the randomized controlled trials.

XLSX File (Microsoft Excel File), 18 KB

Multimedia Appendix 2

The analysis of the event describes the use, user, and technology context in the studied interventions.

XLSX File (Microsoft Excel File), 18 KB

Multimedia Appendix 3

The analysis of the strategy describes the message and route for presenting information in the studied intervention.

XLSX File (Microsoft Excel File), 17 KB

Multimedia Appendix 4

Distribution of identified persuasive systems features, contents, and theories as shown by the shaded areas. "Content" refers to the number of contents identified in each intervention. "Theories" refers to the number of theories identified in each intervention. AUT: authority; CRED: credibility support; DIAL: dialogue support; EXP: expertise; PER: personalization; PRA: praise; PRIM: primary task support; RED: reduction; REM: reminder; REW: rewards; RWF: real-world feel; SMO: self-monitoring; SOCI, SLE: social learning; SRO: social role; SUG: suggestion; TAI: tailoring; VER: verifiability.

XLSX File (Microsoft Excel File), 12 KB

Multimedia Appendix 5

The analysis of persuasive features used in the interventions examined.

XLSX File (Microsoft Excel File), 21 KB

Multimedia Appendix 6

PRISMA checklist.

PDF File (Adobe PDF File), 120 KB

  1. Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. Heart disease and stroke statistics—2023 update: A report From the American Heart Association. Circulation. Feb 21, 2023;147(8). [CrossRef]
  2. Jung HG, Yang YK. Factors influencing health behavior practice in patients with coronary artery diseases. Health Qual Life Outcomes. Jan 06, 2021;19(1):3. [FREE Full text] [CrossRef] [Medline]
  3. Suls J, Mogavero JN, Falzon L, Pescatello LS, Hennessy EA, Davidson KW. Health behaviour change in cardiovascular disease prevention and management: meta-review of behaviour change techniques to affect self-regulation. Health Psychol Rev. Mar 29, 2020;14(1):43-65. [FREE Full text] [CrossRef] [Medline]
  4. Oinas-Kukkonen H. Behavior change support systems: A research model and agenda. In: Ploug T, Hasle P, Oinas-Kukkonen H, editors. Persuasive Technology. PERSUASIVE 2010. Lecture Notes in Computer Science, vol 6137. Berlin, Germany. Springer; 2010:4-14.
  5. Oinas-Kukkonen H. A foundation for the study of behavior change support systems. Pers Ubiquit Comput. Jul 19, 2012;17(6):1223-1235. [CrossRef]
  6. van Gemert-Pijnen JE, Nijland N, van Limburg M, Ossebaard HC, Kelders SM, Eysenbach G, et al. A holistic framework to improve the uptake and impact of eHealth technologies. J Med Internet Res. Dec 05, 2011;13(4):e111. [FREE Full text] [CrossRef] [Medline]
  7. Cruz-Cobo C, Bernal-Jiménez MÁ, Vázquez-García R, Santi-Cano MJ. Effectiveness of mHealth interventions in the control of lifestyle and cardiovascular risk factors in patients after a coronary event: systematic review and meta-analysis. JMIR Mhealth Uhealth. Dec 02, 2022;10(12):e39593. [FREE Full text] [CrossRef] [Medline]
  8. Indraratna P, Tardo D, Yu J, Delbaere K, Brodie M, Lovell N, et al. Mobile phone technologies in the management of ischemic heart disease, heart failure, and hypertension: systematic review and meta-analysis. JMIR Mhealth Uhealth. Jul 06, 2020;8(7):e16695. [FREE Full text] [CrossRef] [Medline]
  9. Kuijpers W, Groen WG, Aaronson NK, van Harten WH. A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors. J Med Internet Res. Feb 20, 2013;15(2):e37. [FREE Full text] [CrossRef] [Medline]
  10. Subedi N, Rawstorn JC, Gao L, Koorts H, Maddison R. Implementation of telerehabilitation interventions for the self-management of cardiovascular disease: systematic review. JMIR Mhealth Uhealth. Nov 27, 2020;8(11):e17957. [FREE Full text] [CrossRef] [Medline]
  11. Bohlen L, Michie S, de Bruin M, Rothman A, Kelly M, Groarke H, et al. Do combinations of behavior change techniques that occur frequently in interventions reflect underlying theory? Ann Behav Med. Nov 01, 2020;54(11):827-842. [FREE Full text] [CrossRef] [Medline]
  12. Milne-Ives M, Lam C, De Cock C, Van Velthoven MH, Meinert E. Mobile apps for health behavior change in physical activity, diet, drug and alcohol use, and mental health: systematic review. JMIR Mhealth Uhealth. Mar 18, 2020;8(3):e17046. [FREE Full text] [CrossRef] [Medline]
  13. Oinas-Kukkonen H, Harjumaa M. Persuasive systems design: key issues, process model, and system features. Commun Assoc Inf Sys. 2009;24. [CrossRef]
  14. Spohrer K, Fallon M, Hoehle H, Heinzl A. Designing effective mobile health apps: does combining behavior change techniques really create synergies? Journal of Management Information Systems. Aug 06, 2021;38(2):517-545. [CrossRef]
  15. Merz M, Ackermann L. Design principles of persuasive systems – review and discussion of the persuasive systems design model. In: AMCIS 2021 Proceedings. 2021. Presented at: Americas Conference on Information Systems (AMCIS); August 9-13, 2021:3; Virtual conference. URL: https://aisel.aisnet.org/amcis2021/sig_hci/sig_hci/3
  16. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. Oct 02, 2018;169(7):467-473. [FREE Full text] [CrossRef] [Medline]
  17. Shariful Islam SM, Chow CK, Redfern J, Kok C, Rådholm K, Stepien S, et al. Effect of text messaging on depression in patients with coronary heart disease: a substudy analysis from the TEXT ME randomised controlled trial. BMJ Open. Feb 20, 2019;9(2):e022637. [FREE Full text] [CrossRef] [Medline]
  18. Devi R, Powell J, Singh S. A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial. J Med Internet Res. Sep 12, 2014;16(9):e186. [FREE Full text] [CrossRef] [Medline]
  19. Huo X, Krumholz HM, Bai X, Spatz ES, Ding Q, Horak P, et al. Effects of mobile text messaging on glycemic control in patients with coronary heart disease and diabetes mellitus: a randomized clinical trial. Circ Cardiovasc Qual Outcomes. Sep 2019;12(9):e005805. [CrossRef] [Medline]
  20. Chow CK, Redfern J, Hillis GS, Thakkar J, Santo K, Hackett ML, et al. Effect of lifestyle-focused text messaging on risk factor modification in patients with coronary heart disease: a randomized clinical trial. JAMA. Sep 2015;314(12):1255-1263. [CrossRef] [Medline]
  21. Zheng X, Spatz ES, Bai X, Huo X, Ding Q, Horak P, et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circ Cardiovasc Qual Outcomes. Apr 2019;12(4):e005616. [CrossRef] [Medline]
  22. Vernooij JWP, Kaasjager HAH, van der Graaf Y, Wierdsma J, Grandjean HMH, Hovens MMC, et al. SMARTStudy Group. Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial. BMJ. Jun 12, 2012;344:e3750. [FREE Full text] [CrossRef] [Medline]
  23. Zhang H, Jiang Y, Nguyen HD, Poo DCC, Wang W. The effect of a smartphone-based coronary heart disease prevention (SBCHDP) programme on awareness and knowledge of CHD, stress, and cardiac-related lifestyle behaviours among the working population in Singapore: a pilot randomised controlled trial. Health Qual Life Outcomes. Mar 14, 2017;15(1):49. [FREE Full text] [CrossRef] [Medline]
  24. Reid RD, Morrin LI, Beaton LJ, Papadakis S, Kocourek J, McDonnell L, et al. Randomized trial of an internet-based computer-tailored expert system for physical activity in patients with heart disease. Eur J Prev Cardiol. Dec 2012;19(6):1357-1364. [CrossRef] [Medline]
  25. Bae J, Woo S, Lee J, Park S, Kwon SW, Choi SH, et al. mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR Mhealth Uhealth. Sep 24, 2021;9(9):e29928. [FREE Full text] [CrossRef] [Medline]
  26. Pfaeffli Dale L, Whittaker R, Jiang Y, Stewart R, Rolleston A, Maddison R. Text message and internet support for coronary heart disease self-management: results from the Text4Heart randomized controlled trial. J Med Internet Res. Oct 21, 2015;17(10):e237. [FREE Full text] [CrossRef] [Medline]
  27. Dorje T, Zhao G, Tso K, Wang J, Chen Y, Tsokey L, et al. Smartphone and social media-based cardiac rehabilitation and secondary prevention in China (SMART-CR/SP): a parallel-group, single-blind, randomised controlled trial. Lancet Digit. Nov 2019;1(7):e363-e374. [CrossRef]
  28. Duan YP, Liang W, Guo L, Wienert J, Si GY, Lippke S. Evaluation of a web-based intervention for multiple health behavior changes in patients with coronary heart disease in home-based rehabilitation: pilot randomized controlled trial. J Med Internet Res. Nov 19, 2018;20(11):e12052. [FREE Full text] [CrossRef] [Medline]
  29. Frederix I, Van Driessche N, Hansen D, Berger J, Bonne K, Alders T, et al. Increasing the medium-term clinical benefits of hospital-based cardiac rehabilitation by physical activity telemonitoring in coronary artery disease patients. Eur J Prev Cardiol. Feb 2015;22(2):150-158. [CrossRef] [Medline]
  30. Indraratna P, Biswas U, McVeigh J, Mamo A, Magdy J, Vickers D, et al. A smartphone-based model of care to support patients with cardiac disease transitioning from hospital to the community (TeleClinical Care): pilot randomized controlled trial. JMIR Mhealth Uhealth. Feb 28, 2022;10(2):e32554. [FREE Full text] [CrossRef] [Medline]
  31. Kamal AK, Khalid W, Muqeet A, Jamil A, Farhat K, Gillani SRA, et al. Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study). PLoS One. 2018;13(12):e0197671. [FREE Full text] [CrossRef] [Medline]
  32. Li Y, Gong Y, Zheng B, Fan F, Yi T, Zheng Y, et al. Effects on adherence to a mobile app-based self-management digital therapeutics among patients with coronary heart disease: pilot randomized controlled trial. JMIR Mhealth Uhealth. Feb 15, 2022;10(2):e32251. [FREE Full text] [CrossRef] [Medline]
  33. Maddison R, Pfaeffli L, Whittaker R, Stewart R, Kerr A, Jiang Y, et al. A mobile phone intervention increases physical activity in people with cardiovascular disease: Results from the HEART randomized controlled trial. Eur J Prev Cardiol. Jun 2015;22(6):701-709. [CrossRef] [Medline]
  34. Maddison R, Rawstorn JC, Stewart RAH, Benatar J, Whittaker R, Rolleston A, et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial. Heart. Jan 2019;105(2):122-129. [FREE Full text] [CrossRef] [Medline]
  35. Maddison R, Jiang Y, Stewart R, Scott T, Kerr A, Whittaker R, et al. An intervention to improve medication adherence in people with heart disease (Text4HeartII): randomized controlled trial. JMIR Mhealth Uhealth. Jun 09, 2021;9(6):e24952. [FREE Full text] [CrossRef] [Medline]
  36. Ni Z, Wu B, Yang Q, Yan LL, Liu C, Shaw RJ. An mHealth intervention to improve medication adherence and health outcomes among patients with coronary heart disease: randomized controlled trial. J Med Internet Res. Mar 09, 2022;24(3):e27202. [FREE Full text] [CrossRef] [Medline]
  37. Park LG, Howie-Esquivel J, Chung ML, Dracup K. A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns. Feb 2014;94(2):261-268. [CrossRef] [Medline]
  38. Pfaeffli Dale L, Whittaker R, Dixon R, Stewart R, Jiang Y, Carter K, et al. Acceptability of a mobile health exercise-based cardiac rehabilitation intervention: a randomized trial. J Cardiopulm Rehabil Prev. 2015;35(5):312-319. [CrossRef] [Medline]
  39. Putra R, Rochmawati I, Prima D. The impact of mobile application: "Friends of Heart" in knowledge and compliance of patients with coronary heart disease. Pharm Educ. 2022;22(2):36-40. [CrossRef]
  40. Silarova B, Sharp S, Usher-Smith JA, Lucas J, Payne RA, Shefer G, et al. Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial. Heart. Jul 30, 2019;105(13):982-989. [FREE Full text] [CrossRef] [Medline]
  41. Snoek JA, Prescott EI, van der Velde AE, Eijsvogels TMH, Mikkelsen N, Prins LF, et al. Effectiveness of home-based mobile guided cardiac rehabilitation as alternative strategy for nonparticipation in clinic-based cardiac rehabilitation among elderly patients in Europe: a randomized clinical trial. JAMA Cardiol. Apr 01, 2021;6(4):463-468. [FREE Full text] [CrossRef] [Medline]
  42. Song Y, Ren C, Liu P, Tao L, Zhao W, Gao W. Effect of smartphone-based telemonitored exercise rehabilitation among patients with coronary heart disease. J Cardiovasc Transl Res. Aug 2020;13(4):659-667. [FREE Full text] [CrossRef] [Medline]
  43. Thakkar J, Redfern J, Thiagalingam A, Chow CK. Patterns, predictors and effects of texting intervention on physical activity in CHD - insights from the TEXT ME randomized clinical trial. Eur J Prev Cardiol. Nov 20, 2016;23(17):1894-1902. [CrossRef] [Medline]
  44. Torri A, Panzarino C, Scaglione A, Modica M, Bordoni B, Redaelli R, et al. Promotion of home-based exercise training as secondary prevention of coronary heart disease: a pilot web-based intervention. J Cardiopulm Rehabil Prev. Jul 2018;38(4):253-258. [CrossRef] [Medline]
  45. Yudi MB, Clark DJ, Tsang D, Jelinek M, Kalten K, Joshi S, et al. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial. Coron Artery Dis. Aug 01, 2021;32(5):432-440. [CrossRef] [Medline]
  46. Santo K, Singleton A, Rogers K, Thiagalingam A, Chalmers J, Chow CK, et al. Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial. Heart. Feb 27, 2019;105(4):323-329. [CrossRef] [Medline]
  47. Matthews J, Win KT, Oinas-Kukkonen H, Freeman M. Persuasive technology in mobile applications promoting physical activity: a systematic review. J Med Syst. Mar 2016;40(3):72. [CrossRef] [Medline]
  48. Karppinen P, Oinas-Kukkonen H, Alahäivälä T, Jokelainen T, Keränen AM, Salonurmi T, et al. Persuasive user experiences of a health behavior change support system: A 12-month study for prevention of metabolic syndrome. Int J Med Inform. Dec 2016;96:51-61. [CrossRef] [Medline]
  49. Ekpezu AO, Wiafe I, Oinas-Kukkonen H. Enhancing Perceived Health Competence: The Impact of Persuasive Social Support Features in Health and Fitness Apps. Int J Hum–Comp Interact. Nov 21, 2023:1-15. [CrossRef]
  50. Bashi N, Fatehi F, Fallah M, Walters D, Karunanithi M. Self-management education through mhealth: review of strategies and structures. JMIR Mhealth Uhealth. Oct 19, 2018;6(10):e10771. [FREE Full text] [CrossRef] [Medline]
  51. Connell LE, Carey RN, de Bruin M, Rothman AJ, Johnston M, Kelly MP, et al. Links between behavior change techniques and mechanisms of action: an expert consensus study. Ann Behav Med. Jul 17, 2019;53(8):708-720. [FREE Full text] [CrossRef] [Medline]
  52. Smids J. The voluntariness of persuasive technology. In: Bang M, Ragnemalm EL, editors. Persuasive Technology. Design for Health and Safety. PERSUASIVE 2012. Lecture Notes in Computer Science, vol 7284. Berlin, Germany. Springer; 2012:123-132.
  53. Tang A. Software designers, are you biased? In: SHARK '11: Proceedings of the 6th International Workshop on SHAring and Reusing Architectural Knowledge. New York, NY. Association for Computing Machinery; 2011:1-8.
  54. Materia FT, Smyth JM. Acceptability of intervention design factors in mHealth intervention research: experimental factorial study. JMIR Mhealth Uhealth. Jul 26, 2021;9(7):e23303. [FREE Full text] [CrossRef] [Medline]
  55. Agyei E, Miettunen J, Oinas-Kukkonen H. Effective interventions and features for coronary heart disease: a meta-analysis. Behaviour & Information Technology. May 19, 2023:1-17. [CrossRef]
  56. Goodwin L, Ostuzzi G, Khan N, Hotopf MH, Moss-Morris R. Can we identify the active ingredients of behaviour change interventions for coronary heart disease patients? a systematic review and meta-analysis. PLoS One. 2016;11(4):e0153271. [FREE Full text] [CrossRef] [Medline]
  57. Agyei E, Oinas-Kukkonen H, Nyman V, Virkkula T, Oikarinen N, Merikallio H, et al. Assessing interventional components in a weight loss app. 2023. Presented at: 56th Hawaii International Conference on System Sciences; January 3-6, 2023:2953-2962; Maui, HI. URL: https://hdl.handle.net/10125/102994 [CrossRef]
  58. Oinas-Kukkonen H. Personalization myopia: a viewpoint to true personalization of information systems. In: Mindtrek '18: Proceedings of the 22nd International Academic Mindtrek Conference. New York, NY. Association for Computing Machinery; 2018:88-91.
  59. Oinas-Kukkonen H, Pohjolainen S, Agyei E. Mitigating issues with/of/for true personalization. Front Artif Intell. Apr 26, 2022;5:844817. [FREE Full text] [CrossRef] [Medline]
  60. Chatterjee A, Prinz A, Gerdes M, Martinez S. Digital interventions on healthy lifestyle management: systematic review. J Med Internet Res. Nov 17, 2021;23(11):e26931. [FREE Full text] [CrossRef] [Medline]
  61. Handayani PW, Gelshirani NB, Azzahro F, Pinem AA, Hidayanto AN. The influence of argument quality, source credibility, and health consciousness on satisfaction, use intention, and loyalty on mobile health application use. Informatics in Medicine Unlocked. 2020;20:100429. [CrossRef]


BCSS: behavior change support system
CAD: coronary artery disease
CHD: coronary heart disease
PICO: Population, Intervention, Comparison, and Outcome
PRISMA-ScR: Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews
PSD: Persuasive Systems Design
RCT: randomized controlled trial


Edited by A Mavragani; submitted 02.06.23; peer-reviewed by W Liang, Q Ding; comments to author 19.07.23; revised version received 21.08.23; accepted 01.05.24; published 19.06.24.

Copyright

©Eunice Eno Yaa Frimponmaa Agyei, Akon Ekpezu, Harri Oinas-Kukkonen. Originally published in JMIR Cardio (https://cardio.jmir.org), 19.06.2024.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cardio, is properly cited. The complete bibliographic information, a link to the original publication on https://cardio.jmir.org, as well as this copyright and license information must be included.